239 related articles for article (PubMed ID: 24713656)
1. Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.
Amato KR; Wang S; Hastings AK; Youngblood VM; Santapuram PR; Chen H; Cates JM; Colvin DC; Ye F; Brantley-Sieders DM; Cook RS; Tan L; Gray NS; Chen J
J Clin Invest; 2014 May; 124(5):2037-49. PubMed ID: 24713656
[TBL] [Abstract][Full Text] [Related]
2. EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer.
Amato KR; Wang S; Tan L; Hastings AK; Song W; Lovly CM; Meador CB; Ye F; Lu P; Balko JM; Colvin DC; Cates JM; Pao W; Gray NS; Chen J
Cancer Res; 2016 Jan; 76(2):305-18. PubMed ID: 26744526
[TBL] [Abstract][Full Text] [Related]
3. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
5. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer.
Song W; Kim LC; Han W; Hou Y; Edwards DN; Wang S; Blackwell TS; Cheng F; Brantley-Sieders DM; Chen J
Mol Cancer Res; 2020 Nov; 18(11):1735-1743. PubMed ID: 32753469
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.
Guo C; Shao R; Correa AM; Behrens C; Johnson FM; Raso MG; Prudkin L; Solis LM; Nunez MI; Fang B; Roth JA; Wistuba II; Swisher SG; Lin T; Pataer A
J Thorac Oncol; 2013 Mar; 8(3):301-8. PubMed ID: 23370317
[TBL] [Abstract][Full Text] [Related]
8. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
9. Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.
Zhou Y; Yamada N; Tanaka T; Hori T; Yokoyama S; Hayakawa Y; Yano S; Fukuoka J; Koizumi K; Saiki I; Sakurai H
Nat Commun; 2015 Jul; 6():7679. PubMed ID: 26158630
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.
Volz C; Breid S; Selenz C; Zaplatina A; Golfmann K; Meder L; Dietlein F; Borchmann S; Chatterjee S; Siobal M; Schöttle J; Florin A; Koker M; Nill M; Ozretić L; Uhlenbrock N; Smith S; Büttner R; Miao H; Wang B; Reinhardt HC; Rauh D; Hallek M; Acker-Palmer A; Heukamp LC; Ullrich RT
Cell Rep; 2020 Apr; 31(4):107568. PubMed ID: 32348765
[TBL] [Abstract][Full Text] [Related]
11. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
12. Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer.
Brannan JM; Dong W; Prudkin L; Behrens C; Lotan R; Bekele BN; Wistuba I; Johnson FM
Clin Cancer Res; 2009 Jul; 15(13):4423-30. PubMed ID: 19531623
[TBL] [Abstract][Full Text] [Related]
13. Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells.
Allocca C; Cirafici AM; Laukkanen MO; Castellone MD
Thyroid; 2021 Jan; 31(1):76-87. PubMed ID: 32762307
[No Abstract] [Full Text] [Related]
14. Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.
Cummings CT; Zhang W; Davies KD; Kirkpatrick GD; Zhang D; DeRyckere D; Wang X; Frye SV; Earp HS; Graham DK
Mol Cancer Ther; 2015 Sep; 14(9):2014-22. PubMed ID: 26162689
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer.
Tong X; Tanino R; Sun R; Tsubata Y; Okimoto T; Takechi M; Isobe T
Respir Res; 2019 Dec; 20(1):270. PubMed ID: 31791326
[TBL] [Abstract][Full Text] [Related]
16. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
17. Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
Howe GA; Xiao B; Zhao H; Al-Zahrani KN; Hasim MS; Villeneuve J; Sekhon HS; Goss GD; Sabourin LA; Dimitroulakos J; Addison CL
PLoS One; 2016; 11(3):e0150567. PubMed ID: 26962872
[TBL] [Abstract][Full Text] [Related]
18. TC-1 overexpression promotes cell proliferation in human non-small cell lung cancer that can be inhibited by PD173074.
Lei J; Li W; Yang Y; Lu Q; Zhang N; Bai G; Zhong D; Su K; Liu B; Li X; Wang Y; Wang X
PLoS One; 2014; 9(6):e100075. PubMed ID: 24941347
[TBL] [Abstract][Full Text] [Related]
19. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury.
Park BH; Shin MH; Douglas IS; Chung KS; Song JH; Kim SY; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):519-529. PubMed ID: 29216437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]